SCHEMBL5613324

SCHEMBL5613324

CN1CCC([N+](Cc2cc(-c3ccc4[nH]ccc4c3)ccc2F)(C(=O)c2cccc(OC(F)(F)F)c2)c2ccccc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 2/20 0.39
▸ RIPK1 Q13546 1/20 0.34
▸ CHRM4 P08173 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ MAP4K1 Q92918 1/20 0.33
▸ FASN P49327 1/20 0.33
▸ KDR P35968 1/20 0.32
▸ PIM2 Q9P1W9 2/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ PRKD3 O94806 1/20 0.32
▸ PRKCG P05129 1/20 0.32
▸ PHKG2 P15735 1/20 0.32
▸ RPS6KB1 P23443 1/20 0.32
▸ MARK3 P27448 1/20 0.32
▸ PRKCI P41743 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3693932 0.80 GHSR (0.42) GHSRRIPK1FASN
SCHEMBL3697727 0.73 HTR2A (0.43) GHSRFASN
SCHEMBL3703934 0.70 HTR2A (0.47) —
SCHEMBL3699072 0.69 BRD4 (0.40) RIPK1FASNKDRROCK2WDR5
SCHEMBL6731178 0.67 F2 (0.38) FASNWDR5
SCHEMBL27711111 0.66 ABL1 (0.45) ABL1FASNROCK2TRPV1
SCHEMBL3698083 0.66 HTR2A (0.42) ABL1FASNWDR5
SCHEMBL3696842 0.65 BRAF (0.41) ABL1FASNWDR5
SCHEMBL13604953 0.65 KDM4E (0.48) FASN
SCHEMBL28030810 0.65 NPC1 (0.57) GHSRABL1FFAR4PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851199-A1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS Aventis Pharmaceuticals, Inc. (US) 2007-11-07 — — EP claimed
WO-2006086705-A1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2006-08-17 — — WO claimed
Send feedback